Ocular Therapeutix: Q4 Earnings Insights

Ocular Therapeutix OCUL reported its Q4 earnings results on Monday, March 11, 2024 at 04:00 PM.

Here's what investors need to know about the announcement.

Ocular Therapeutix missed estimated earnings by -17.0%, reporting an EPS of $-0.35 versus an estimate of $-0.3.

Revenue was up $726 thousand from the same period last year.

Last quarter the company beat on EPS by $0.04 which was followed by a 13.0% drop in the share price the next day.

Here's a look at Ocular Therapeutix's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.29	-0.29	-0.26	-0.25
EPS Actual	-0.25	-0.26	-0.39	-0.24
Revenue Estimate	15.25M	14.64M	14.10M	13.53M
Revenue Actual	15.08M	15.19M	13.37M	14.08M

To track all earnings releases for Ocular Therapeutix visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar